WingoP, TongT, BoldenS. Cancer statistics. CA Cancer J Clin1995;45:8–30.
2.
WinawerS, ZauberA, HoM, O'BrienM, GottliebL. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med1993;329:1977–81.
3.
LynchH, SmyrkT, WatsonP, LanspaS, LynchJ. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology1993;104:1535–49.
4.
RustgiA. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med1994;331:1694–702.
5.
VasenH, MecklinJ-P, KhanP, LynchH. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum1991;34:424–5.
6.
ItzkowitzS, KimY. Polyps and benign neoplasms of the colon. In: SleisengerM, FordtranJ, eds. Gastrointestinal disease. Philadelphia: WB Saunders; 1993:1402–29.
7.
MaskensA. Histogenesis of adenomatous polyps in the human large intestine. Gastroenterology1979;77:1245–51.
8.
MorsonB, SobinL. Histologic typing of intestinal tumors. Geneva: World Health Organization, 1976.
9.
RiddelR, GoldmanH, RansohoffD, ApplemanH, HaggittR. Dysplasia in inflammatory bowel diseases: standardized classification with provisional clinical application. Hum Pathol1983;14:931–68.
10.
O'BrienM, WinawerS, ZauberA, GottliebL, SternbergS. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology1990;98:371–9.
11.
MutoT, BusseyH, MorsonB. The evolution of cancer of the colon and rectum. Cancer1975;36:2251–70.
12.
VogelsteinB, FearonE, HamiltonS, KernS, PreisingerA. Genetic alterations during colorectal-tumor development. N Engl J Med1988;319:525–32.
13.
BolandC, SatoJ, ApplemanH, BresalierR, FeinbergA. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Medicine1995;1:902–9.
14.
GrodenJ, ThliverisA, SamowitzW, CarlsonM, GelbertL, AlbertsenH, JosllynG, StevensJ. Identification and characterization of the familial adenomatous polyposis coli gene. Cell1991;66:589–600.
15.
RubinfeldB, SouzaB, AlbertI, MullerO, ChamberlainS, MasiarzF, PolakisP, MunemitsuS. Association of the APC gene product with B-catenin. Science1993;262:1731–3.
16.
SuL-K, VogelsteinB, KinzlerK. Association of the APC tumor suppressor protein with catenins. Science1993;262:1734–7.
17.
HinckL, NathkeI, PapkoffJ, NelsonW. B-catenin: a common target for the regulation of cell adhesion by wnt-1 and src signaling pathways. Trends Biochem Sci1994;19:538–42.
18.
CollinsJ, FlemingT. Epithelial differentiation in the mouse preimplantation embryo: making adhesive cell contacts for the first time. Trends Biochem Sci1995;20:307–12.
19.
MoodieS, WolfmanA. The 3Rs of life: ras, raf and growth regulation. Trends Genet1994;10:44–8.
20.
PowellS, ZilzN, BryanT, HamiltonS, ThibodeauS, VogelsteinB Kinzler, KinzlerK. APC Mutations occur early during colorectal tumorigenesis. Nature1992;359:235–7.
21.
EnochT, NorburyC. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem Sci1995;20:426–30.
22.
PeltomakiP, AaltonenL, SistonenP, PylkkanenL, JarvinenH, GreenJ, JassJ, WeberJ, LeachF. Genetic mapping of a locus predisposing to human colorectal cancer. Science1993;260:810–2.
23.
AaltonenL, PeltomakiP, LeachF, SistonenP, PylkkanenL, PowellS, JenJ, HamiltonS. Clues to the pathogenesis of familial colorectal cancer. Science1993;260:812–6.
24.
ThibodeauS, SchaidD, BrenG. Microsatellite instability in cancer of the proximal colon. Science1993;260:816–9.
25.
SeniorR. Stalking the start of colon cancer. Science1994;263:1559–60.
26.
ChungD, RustgiA. DNA mismatch repair and cancer. Gastroenterology1995;109:1685–99.
27.
ModrichP. Mismatch repair, genetic stability, and cancer. Science1995;266:1959–60.
28.
LeachF, NicolaidesN, PapadopoulosN, LiuB, JenJ, ParsonsR, SistonenP. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell1993;75:1215–25.
29.
FishelR, LescoeM, RaoM, CopelandN, JenkinsN, GarberJ, KaneM. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell1993;75:1027–38.
30.
PapadopoulosN, NicolaidesN, RubenS, CarterK, RosenC, FraserC. Mutation of a mutL homolog in hereditary colon cancer. Science1994;263:1625–9.
31.
BronnerC, BakerS, MorrisonP, WarrenG, SmithL, LecoeM, LipfordJ. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary nonpolyposis colon cancer. Nature1994;368:258–61.
32.
NicolaidesN, PapadopoulosN, LluB, CarterK, RubenS, RosenC, HaseltineW, FleischmannR. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature1994;371:75–80.
33.
ParsonsR, LiG-M, LongleyM, FangW, PapadopoulosN, JenJ, KinzlerK. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell1993;75:1227–36.
34.
LiuB, NicolaidesN, MarkowitzS, WillsonJ, ParsonsR, JenJ, HamiltonS. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet1995;9:48–55.
35.
LazarV, GrandjouanS, BognelC, CouturierD, RougierP, BelletD. Accumulation of multiple mutations in tumour suppressor genes during colorectal fumorigenesis in HNPCC patients. Hum Mol Genet1994;3:2257–60.
36.
LiuB, HamiltonS, KinzlerK. Polymerase and variants in RER colorectal tumours. Nat Genet1995;9:10–1.
37.
PapadopoulosN, NicolaidesN, LiuB, ParsonsR, LengauerC, PalomboF, MarkowitzS. Mutations of GTBP in genetically unstable cells. Science1995;268:1915–7.
38.
PalomboF, GallinariP, LaccarinoI, LettieriT, HughesM, TruoinO, HsuanJ, JiricnyJ. GTBP. A 160-Kilodalton protein essential for mismatch-binding activity in human cells. Science1995;268:1912–4.
39.
CorreaP, StrongJ, ReifA, JohnsonW. The epidemiology of colorectal polyps. Prevalence in New Orleans and international comparisons. Cancer1977;39:2258–64.
40.
BergeT, EkelundG, MeffnerC, PhilB, WenckertP. A carcinoma of the colon and rectum in a defined population. ACTA Chio Scand1973;438:1–86.
41.
RickertR, AuerbachO, GarfinkelL, FrascaJ. Adenomatous lesions of the large bowel: an autopsy survey. Cancer1979;43:1847–57.
42.
WilliamsA, BalasooriyaB, DayD. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut1982;23:835–42.
43.
JohnsonD, GurneyM, VolpeR, JonesD, ChoanianS, AvalosJ, BuckJ. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol1990;85:969–74.
44.
LiebermanD, SmithF. Screening for colon malignancy with colonoscopy. Am J Gastroenterol1991;86:946–51.
45.
DiSarioJ, FotchP, MaiH, PardyK, ManneR. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol1991;86:941–5.
46.
BazzoliF, FossiS, SottiliS, PozzatoP, ZagariR, MorelliM, TaroniF, RodaE. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology1995;109:783–8.
47.
RexD, LehmanG, HawesR, UlbrightT, SmithJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology1991;100:64–7.
48.
RexD, LehmanG, UlbrightT, SmithJ, PoundD, HawesR, HelperD, LiW. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol1993;88:825–31.
49.
BurtR, BishopD, CannonL, DowdleM, LeeR, SkolnickM. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med1985;312:1540–4.
50.
Cannon-AlbrightL, SkolnickM, BishopD, LeeR, BurtR. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med1988;319:533–7.
51.
BonelliL, MartinesH, ConioM, BruzziP, AsteH. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer1988;41:513–7.
52.
BakerJ, GathrightJ, TimmckeA, HicksT, FerrariB, RayJ. Colonoscopic screening of asymptomatic patients with a family history of colon cancer. Dis Colon Rectum1990;33:926–30.
53.
GuillemJ, FordeK, TreatM, NeugutA, O'TooleK, DiamondB. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. Dis Colon Rectum1992;35:523–9.
54.
GrossmanS, MilosM, TekawaI, JewellN. Colonoscopic screening of persons with suspected risk factors for colon cancer: II. past history of colorectal neoplasms. Gastroenterology1989;96:299–306.
55.
FuchsC, GiovannucciE, ColditzG, HunterD, SpeizerF, WillettW. A prospective study of family history and the risk of colorectal cancer. N Engl J Med1994;331:1669–74.
56.
WinawerS, ZauberA, GerdesH, O'BrienM, GottliebL, BondJ, WayeJ, ShikeM, KurtzR. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med1996;334:82–7.
57.
TrockB, LanzaE, GreenwaldP. Dietary fiber, vegetables, and colon cancer: Critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst1990;82:650–61.
58.
WynderE, ReddyB, WeisburgerJ. Environmental dietary factors in colorectal cancer. Cancer1992;70:1222–8.
59.
DollR, PetoR. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst1987;66:1191–208.
60.
WillettW, StammpferM, ColditzG, RosnerB, SpeizerF. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med1990;323:1664–72.
61.
GiovanucciE, StampferM, ColditzG, RimmE. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst1992;84:91–6.
62.
VargasP, AlbertsD. Primary prevention of colorectal cancer through dietary modification. Cancer1992;70:1229–35.
63.
MacraeF, MacLennanR, WardM, WahlqvistM, NguM. A randomized controlled trial of fat, fibre and betacarotene on colorectal adenomas. Gastroenterology1995;108:A501.
64.
BremnerC, AckermanL. Polyps and carcinoma of the large bowel in the South African Bantu. Cancer1970;26:991–9.
65.
BresalierR, KimY. Malignant neoplasms of the large intestine. Philadelphia: WB Saunders1993:1449–93.
66.
WinawerS, SchottenfeldD, FlehingerB. Colorectal cancer screening. J Natl Cancer Inst1991;83:243–53.
67.
BondJ. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. Ann Intern Med1993;119:836–43.
68.
ToribaraN, SleisengerM. Screening for colorectal cancer. N Engl J Med1995;332:861–85.
69.
WinawerS, FlehingerB, SchottenfeldD, MillerD. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst1993;85:1311–8.
70.
MandelJ, BondJ, ChurchT, SnoverD, BradleyGM, SchumanL, EdererF. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med1993;328:1365–71.
71.
HardcastleJ, ThomasW, ChamberlainJ. Randomized controlled trial of fecal occult blood screening for colorectal cancer. Lancet1989;1:1160–4.
72.
KewenterJ, BjorkS, HaglundE. Screening and rescreening for colorectal cancer. Cancer1988;62:645–51.
73.
KronborgO, GengerC, WormJ, PedersenS, JenJ, OlsenJ, BertelsenK. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol1992;27:47–52.
74.
AhlquistD, WieandH, MoertelC. Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using hemoccult and hemo quant tests. JAMA1993;269:1262–7.
75.
SelbyJ, FriedmanG, QuesenberryC, WeissN. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med1992;326:653–7.
76.
NewcombP, NorfleetR, StorerB, SurawiczS, MarcusP. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst1995;84:1572–5.
77.
GilbertsenV. Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer. Cancer1974;34:936–9.
78.
AtkinW, MorsonB, CuzickJ. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med1992;326:658–62.
79.
CuzickJ, AtkinW, NorthoverJ, WhynesD. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet1993;341:736–40.
80.
RexD, LehmanG, UlbrightT, SmithJ, HawesR. The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination. Gastroenterology1994;106:593–5.
81.
WinawerS, St. JohnD, BondJ, RosenP, BurtR, WayeJ, KurtzR, ShikeM. Prevention of colorectal cancer: guidelines based on new data. World Health Organization1995;73:7–10.
82.
MarraG, BolandC. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst1995;87:1114–25.
83.
AaltonenL, PeltomakiP, MecklinJ-P, JarvinenH, JassJ, GreenJ, LynchH, WatsonP. Replication erors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res1994;54:1645–8.
84.
PeltomakiP, LoebL, LiuB, WoosterR, BisgaardM, LotheR, IonovY. Microsatellite instability as an indicator of hereditary susceptibility to colon cancer. Gastroenterology1995;109:2031–3.
85.
LiuB, FarringtonS, PetersenG, HamiltonS, ParsonsR, JenJ, WyllieA, KinzlerK, DunlopM. Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med1995;1:348–52.
86.
JarvinenH, MecklinJ-P, SistonenP. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology1995;108:1405–11.
87.
VasenH, MecklinJ-P, WatsonP, UtsunomiyaJ, BertarioL, LynchP, SvendsenL, MullerH. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. Dis Colon Rectum1993;36:1–4.
88.
LuceM, MarraG, ChauhanD, LaghiL, CarethersJ, CherianS, HawnM, KoiM, BinnieC. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology1995;109:1368–74.
89.
Nystrom-LahtiM, KristoP, NicolaidesN, ChangL, AaltonenA, MoisioA, JarvinenH, MecklinJ, KinzlerK, VogelsteinB, De La ChapelleA, PeltomakiP. Founding mutations and alu-mediated recombination in hereditary colon cancer. Nature Medicine1995;1:1203–6.
90.
HamiltonS, LiuB, ParsonsR, PapadopoulosN, JenJ, PowellS, KrushA, CohenZ, BugerP. The molecular basis of Turcot's syndrome. N Engl J Med1995;332:839–47.
BertoniG, SassatelliR, NigrisoliE, TansiniP, RoncucciL, BedogniG. First observation of microadenomas in the lleal mucosa of patients with familial adenomatous polyposis and colectomies. Gastroenterology1995;109:374–80.
93.
PowellS, PetersenG, KrushA, BookerS, JenJ, GiardielloF, HamiltonS, VogelsteinB. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med1993;329:1982–7.
94.
WinawerS, ZauberA, O'BrienM, GottliebL, SternbergS, WayeJ, BondJ, ShikeM, KurtzR. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med1993;328:901–6.
95.
NeugutA, JacobsonJ, AhsanH, SantosJ, GarowskiG, FordeK, TreatM, WayeJ. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology1995;108:402–8.
NugentF, HaggittR, GilpinP. Cancer surveillance in ulcerative colitis. Gastroenterology1991;100:1241–8.
98.
SacharD, GreensteinA, BurmnerG, NystromL, ChoiP. Clinical and colonoscopic surveillance in ulcerative colitis: are we saving colons or saving lives?Gastroenterology1993;105:588–97.
99.
Lennard-JonesJ. Colitic cancer: supervision, surveillance, or surgery. Gastroenterology1995;109:1388–91.
100.
ChoiP, NugentF, SchoetzD, SilvermanM, HaggitR. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology1993;105:418–24.
101.
ConnellW, LennardJ, WilliamsC, TalbotI, PriceA, WilkinsonK. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology1994;107:934–44.
102.
RozenP, BaratzM, FeferF, GilatT. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology1995;108:1361–70.
103.
BrentnallT, RubinC, CrispinD, StevensA, BatchelorR, HaggittR, BronnerM. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology1995;109:151–5.
104.
SidranskyD, TokinoT, HamiltonS, FrostP, VogelsteinB, KinzlerK, LevinB. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science1992;256:102–5.
